Tag Archives: NSPR

Top 5 Heal Care Stocks To Watch Right Now

The last six month might not have gone investors’ way, especially after the blockbuster returns seen in 2017. Benchmark indices managed to stay afloat with the Sensex up about 4 percent in the last six months of 2018 but the bigger carnage was seen in the small and midcap space.

If we look at the performers of the last six months, most wealth creators are from the midcap and largecap space. Top 10 stocks that rose 30-80 percent in 2018 despite global and domestic headwinds include: Indiabulls Ventures, Firstsource Solutions, V-Mart Retail, NIIT Technologies, Mindtree, Tech Mahindra, Larsen & Toubro Infotech, KPIT Technologies, Mphasis and Jubilant FoodWorks.

“Stocks which have returned over 50 percent are fundamentally still strong and the momentum in these stocks is expected to continue going forward,” Ritesh Ashar, Chief Strategy Officer at KIFS Trade Capital, said.

Top 5 Heal Care Stocks To Watch Right Now: NO Name(ACI)

Advisors’ Opinion:

  • [By Garrett Baldwin]

    Before the bell, the U.S. Bureau of Economic Analysis reported its second GDP estimate for the fourth quarter. U.S. economic growth came in at 2.6%, a figure that topped consensus expectations. Q2 and Q3 2018 GDP growth came in at fabulous levels – 4.2% and 3.4%, respectively. However, investors predicted the reading would come in lower due to the government shutdown during the fourth quarter. In other economic news, the Department of Labor this morning reported weekly jobless claims at 225,000. That figure is slightly higher than the 220,000 expected by economists. The price of Bitcoin is currently hovering just under $4,000. We’ve been watching a long process of consolidation at these levels for several weeks. Despite short-term pain in the markets, Money Morning’s David Zeiler outlines the bullish case for Bitcoin. How high can the price of Bitcoin go? David makes the bullish case that Bitcoin could hit $250,000 by 2025. For more on how to profit from Bitcoin’s next bull cycle, go here now.
    Stocks to Watch Today: JCP, JWN, ACI, BUD
    Shares of J.C. Penney Co. Inc. (NYSE: JCP) popped more than 16% after the embattled retail giant reported earnings. The company topped Wall Street expectations and announced plans to shutter another 18 department stores this year. The company’s balance sheet temporarily improved after it was able to reduce its massive inventory glut. The firm reported EPS of $0.18, topping forecasts by $0.08. Revenue came in at $3.79 billion. Shares of Anheuser Busch Inbev NV (NYSE: BUD) popped more than 5% after the beer brewing giant crushed Wall Street earnings expectations. The Budweiser and Corona maker announced plans to increase its non-alcoholic and low-alcohol drinks business, two areas that continue to show impressive and rising global demand. The Western Union Co. (NYSE: WU) is generating buzz after it announced a $1 billion stock buyback program. In addition, the payment giant said it would sell its Speedpay bill paying bu

Top 5 Heal Care Stocks To Watch Right Now: CGI Group, Inc.(GIB)

Advisors’ Opinion:

  • [By Ethan Ryder]

    CGI (TSE:GIB.A) (NYSE:GIB) had its target price raised by stock analysts at Barclays from C$83.00 to C$89.00 in a report issued on Thursday. Barclays’ price objective points to a potential upside of 7.04% from the stock’s previous close.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on CGI Group (GIB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on CGI Group (GIB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    These are some of the news headlines that may have effected Accern’s scoring:

    Get CGI Group alerts:

    CGI Group (GIB) Upgraded by Zacks Investment Research to “Buy” (americanbankingnews.com) $2.31 Billion in Sales Expected for CGI Group (GIB) This Quarter (americanbankingnews.com) Head-To-Head Contrast: CGI Group (GIB) vs. BlackRock Capital Investment (BKCC) (americanbankingnews.com) $0.82 EPS Expected for CGI Group (GIB) This Quarter (americanbankingnews.com)

    GIB traded down $0.12 on Friday, reaching $57.80. The company’s stock had a trading volume of 133,506 shares, compared to its average volume of 195,152. The company has a market capitalization of $16,644.44, a P/E ratio of 20.79, a P/E/G ratio of 1.92 and a beta of 0.73. CGI Group has a 1 year low of $46.41 and a 1 year high of $59.89. The company has a debt-to-equity ratio of 0.24, a quick ratio of 0.70 and a current ratio of 0.99.

  • [By Ethan Ryder]

    Booz Allen Hamilton (NYSE: BAH) and CGI Group (NYSE:GIB) are both business services companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, profitability, dividends, analyst recommendations, risk, earnings and institutional ownership.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on CGI (GIB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Heal Care Stocks To Watch Right Now: Black Box Corporation(BBOX)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Shares of Black Box Co. (NASDAQ:BBOX) gapped down before the market opened on Wednesday . The stock had previously closed at $1.88, but opened at $1.95. Black Box shares last traded at $2.08, with a volume of 51479 shares trading hands.

  • [By Max Byerly]

    Liberum Capital reissued their hold rating on shares of Tritax Big Box REIT (LON:BBOX) in a research note issued to investors on Friday.

    Separately, Numis Securities lifted their target price on Tritax Big Box REIT from GBX 150 ($1.95) to GBX 153 ($1.99) and gave the company a hold rating in a research report on Monday, August 20th.

  • [By Paul Ausick]

    Black Box Corp. (NASDAQ: BBOX) traded flat Thursday to match its 52-week low of $0.75 after closing Tuesday at $0.75. The stock’s 52-week high is $8.45. Volume was more than 40 times the daily average of about 180,000 shares. The company warned on Tuesday that it could face bankruptcy. Shares rose in Thursday trading and are on track to post a gain of about 30% for the day.

  • [By Logan Wallace]

    Juniper Networks (NYSE: JNPR) and Black Box (NASDAQ:BBOX) are both computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, valuation, analyst recommendations and dividends.

Top 5 Heal Care Stocks To Watch Right Now: Videocon d2h Limited(VDTH)

Advisors’ Opinion:

  • [By Shane Hupp]

    News headlines about Videocon d2h (NASDAQ:VDTH) have trended somewhat positive recently, according to Accern Sentiment Analysis. The research group identifies positive and negative press coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Videocon d2h earned a media sentiment score of 0.18 on Accern’s scale. Accern also gave news headlines about the company an impact score of 44.8019957983193 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

  • [By Logan Wallace]

    Videocon d2h (NASDAQ: VDTH) and MSG Networks (NYSE:MSGN) are both small-cap consumer discretionary companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, valuation, risk, earnings and institutional ownership.

  • [By Joseph Griffin]

    Videocon d2h (NASDAQ: VDTH) and DISCOVERY COMMUNICATIONS INC. Common Stock (NASDAQ:DISCA) are both consumer discretionary companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, institutional ownership, analyst recommendations, risk, profitability and earnings.

Top 5 Heal Care Stocks To Watch Right Now: InspireMD, Inc.(NSPR)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Oragenics, Inc. (NYSE: OGEN) shares surged 66.67 percent to close at $2.00 on Wednesday after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study.
    Sigma Labs, Inc. (NASDAQ: SGLB) shares jumped 49.24 percent to close at $1.97 on Wednesday. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing.
    ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) rose 34.45 percent to close at $9.21. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating.
    Dick's Sporting Goods, Inc. (NYSE: DKS) shares rose 25.82 percent to close at $38.35 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook.
    TapImmune, Inc. (NASDAQ: TPIV) rose 24.15 percent to close at $5.09. WBB Securities upgraded TapImmune from Speculative Buy to Buy.
    Legacy Reserves LP (NASDAQ: LGCY) jumped 23.3 percent to close at $5.98 on Wednesday.
    Summer Infant, Inc. (NASDAQ: SUMR) gained 22.92 percent to close at $1.18 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital.
    Cloud Peak Energy Inc. (NYSE: CLD) rose 21.95 percent to close at $4.00.
    SpartanNash Co (NASDAQ: SPTN) gained 21.4 percent to close at $22.92 after the company reported upbeat earnings for its first quarter on Tuesday.
    Motus GI Holdings, Inc. (NASDAQ: MOTS) rose 17.14 percent to close at $5.40.
    Movado Group, Inc. (NYSE: MOV) gained 16.59 percent to close at $49.20 after the company reported better-than-expected Q1 results and raised its guidance.
    Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) climbed 15.61 percent to close at $8.22. Oramed Pharma disclosed that its patent has been allowed in the US for oral administration of proteins.
    Dorian LPG Ltd. (NYSE: LPG) rose 14.89 percent to close at $8.41. Dorian LPG confirmed receipt of unsolicited proposal fr
  • [By Lisa Levin] Gainers
    Sigma Labs, Inc. (NASDAQ: SGLB) shares rose 90.9 percent to $2.52. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing.
    Oragenics, Inc. (NYSE: OGEN) shares surged 58.4 percent to $1.9005 after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study.
    Dick's Sporting Goods, Inc. (NYSE: DKS) shares climbed 23.2 percent to $37.5370 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook.
    Summer Infant, Inc. (NASDAQ: SUMR) rose 21.9 percent to $1.17 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital.
    TapImmune, Inc. (NASDAQ: TPIV) jumped 18.8 percent to $4.87. WBB Securities upgraded TapImmune from Speculative Buy to Buy.
    Movado Group, Inc. (NYSE: MOV) gained 17.2 percent to $49.45 after the company reported better-than-expected Q1 results and raised its guidance.
    ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) jumped 16.2 percent to $7.96. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating.
    Legacy Reserves LP (NASDAQ: LGCY) rose 15.5 percent to $5.6011.
    InspireMD, Inc. (NYSE: NSPR) gained 13.3 percent to $1.36 following PR announcing sustained benefit of CGuard EPS.
    Immutep Limited (NASDAQ: IMMP) shares climbed 13.2 percent to $2.7724 after the company reported new data from its ongoing TACTI-mel Phase I trial, which evaluated the combination of eftilagimod alpha, its lead compound, with Merck & Co., Inc. (NYSE: MRK)'s Keytruda in unresectable or metastatic melanoma patients, who have had a suboptimal response or had disease progression with keytruda monotherapy..
    SpartanNash Co (NASDAQ: SPTN) rose 12.2 percent to $21.20 after the company reported upbeat earnings for its first quarter on Tuesday.
    Amtech Systems, Inc. (NASDAQ: ASYS) rose 12.1 percent to

Top 10 Medical Stocks To Watch For 2019

Zacks Investment Research upgraded shares of UQM Technologies (NYSEAMERICAN:UQM) from a hold rating to a buy rating in a research note released on Saturday morning. They currently have $1.75 target price on the industrial goods maker’s stock.

According to Zacks, “UQM Technologies, Inc. is a developer and manufacturer of power dense, high efficiency electric motors, generators and power electronic controllers for the automotive, aerospace, medical, military and industrial markets. A major emphasis of the Company is developing products for the alternative energy technologies sector including propulsion systems for electric, hybrid electric, plug-in hybrid electric and fuel cell electric vehicles, under-the-hood power accessories and other vehicle auxiliaries and distributed power generation applications. The Company’s headquarters, engineering and product development center, and motor manufacturing operation are located in Frederick, Colorado. “

Top 10 Medical Stocks To Watch For 2019: CytomX Therapeutics, Inc.(CTMX)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on CytomX Therapeutics (CTMX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    CytomX Therapeutics Inc (NASDAQ:CTMX) CEO Sean A. Mccarthy sold 2,028 shares of the company’s stock in a transaction on Tuesday, July 3rd. The shares were sold at an average price of $25.09, for a total transaction of $50,882.52. Following the completion of the sale, the chief executive officer now owns 84,091 shares of the company’s stock, valued at approximately $2,109,843.19. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on CytomX Therapeutics (CTMX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Chris Lange]

    CytomX Therapeutics Inc. (NASDAQ: CTMX) is presenting on a couple different topics: probody conjugate (CX-2009) treatment in patients with advanced solid tumors and probody drug conjugate targeting CD166 in preclinical antitumor activity. Wedbush has an Outperform rating with a price target of $25, implying upside of 123% from Friday’s closing price of $11.22. The shares have a 52-week range of $10.91 to $35.00. The stock has a consensus price target of $29.20.

  • [By Shane Hupp]

    Shares of CytomX Therapeutics (NASDAQ:CTMX) have earned an average recommendation of “Buy” from the thirteen research firms that are currently covering the firm, MarketBeat reports. Four analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. The average 12-month price target among brokers that have issued ratings on the stock in the last year is $39.86.

Top 10 Medical Stocks To Watch For 2019: Eaton Vance Enhanced Equity Income Fund II(EOS)

Advisors’ Opinion:

  • [By Shane Hupp]

    EOS (CURRENCY:EOS) traded up 9.3% against the US dollar during the 1 day period ending at 20:00 PM E.T. on July 2nd. During the last week, EOS has traded up 8.5% against the US dollar. One EOS token can now be purchased for $8.89 or 0.00135160 BTC on exchanges including Zebpay, CoinEx Market, ChaoEX and Tidex. EOS has a market cap of $7.96 billion and $1.02 billion worth of EOS was traded on exchanges in the last day.

  • [By Ethan Ryder]

    EOS (CURRENCY:EOS) traded 2.8% lower against the dollar during the 24-hour period ending at 23:00 PM E.T. on August 25th. In the last week, EOS has traded down 4% against the dollar. EOS has a total market capitalization of $4.43 billion and approximately $344.84 million worth of EOS was traded on exchanges in the last 24 hours. One EOS coin can now be bought for about $4.89 or 0.00073541 BTC on popular exchanges including Kucoin, Mercatox, ChaoEX and Bitfinex.

  • [By Joseph Griffin]

    EOS (CURRENCY:EOS) traded 0.7% higher against the U.S. dollar during the 1 day period ending at 16:00 PM ET on July 4th. In the last seven days, EOS has traded 13.1% higher against the U.S. dollar. One EOS token can now be purchased for approximately $9.05 or 0.00135304 BTC on major cryptocurrency exchanges including DragonEX, ChaoEX, Hotbit and HitBTC. EOS has a market cap of $8.11 billion and approximately $912.71 million worth of EOS was traded on exchanges in the last 24 hours.

  • [By Stephan Byrd]

    EOS (CURRENCY:EOS) traded 4.1% higher against the US dollar during the 24 hour period ending at 14:00 PM E.T. on June 27th. EOS has a total market capitalization of $7.24 billion and $772.07 million worth of EOS was traded on exchanges in the last 24 hours. Over the last week, EOS has traded down 22.9% against the US dollar. One EOS token can currently be purchased for approximately $8.08 or 0.00131687 BTC on major cryptocurrency exchanges including Kuna, Bibox, Cryptopia and CoinExchange.

Top 10 Medical Stocks To Watch For 2019: Codexis, Inc.(CDXS)

Advisors’ Opinion:

  • [By Logan Wallace]

    Codexis (NASDAQ:CDXS) was downgraded by analysts at ValuEngine from a “strong-buy” rating to a “buy” rating in a research report issued to clients and investors on Monday.

  • [By Keith Noonan, Daniel Miller, and Maxx Chatsko]

    Having even a few of these companies working in your favor over the long term can be a life-changing event. To help put readers on to some high-growth stocks that still have big potential, we asked three Motley Fool investors to profile a top growth investment. Read on to see why they identified Codexis (NASDAQ:CDXS), Activision Blizzard (NASDAQ:ATVI), and Control4 Corporation (NASDAQ:CTRL) as top stocks for growth-seeking investors.

  • [By Ethan Ryder]

    Codexis, Inc. (NASDAQ:CDXS) SVP James Lalonde sold 15,000 shares of the stock in a transaction on Tuesday, July 17th. The stock was sold at an average price of $15.40, for a total value of $231,000.00. Following the sale, the senior vice president now owns 202,566 shares in the company, valued at approximately $3,119,516.40. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

  • [By Jason Hall, Chuck Saletta, and Maxx Chatsko]

    And while investors shouldn’t count Elon Musk and Tesla out, it’s never wise to put all your hopes — and money — on a single company. We asked three investors who write for The Motley Fool — one of whom is a Tesla shareholder — for alternative ideas — stocks they think could put Tesla’s future returns to shame. They put together compelling arguments for Clean Energy Fuels Corp. (NASDAQ:CLNE), Berkshire Hathaway Inc. (NYSE:BRK-A)(NYSE:BRK-B), and Codexis, Inc. (NASDAQ:CDXS). 

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Codexis (CDXS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Codexis (NASDAQ:CDXS) hit a new 52-week high and low during trading on Monday . The company traded as low as $14.45 and last traded at $13.98, with a volume of 520808 shares traded. The stock had previously closed at $13.50.

Top 10 Medical Stocks To Watch For 2019: Pluristem Therapeutics Inc.(PSTI)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Pluristem Therapeutics (PSTI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Here are some of the news headlines that may have impacted Accern’s rankings:

    Get Pluristem Therapeutics alerts:

    Pluristem Therapeutics Inc. (PSTI) Given Consensus Rating of “Buy” by Analysts (americanbankingnews.com) Head-To-Head Analysis: Pluristem Therapeutics (PSTI) & Amgen (AMGN) (americanbankingnews.com) Pre-Eclampsia Treatment Market Outlook 2025, Global Opportunity & Growth Analysis, Key Players – Alnylam … (menafn.com) Flickering Three Stocks: Golden Star Resources Ltd. (NYSE:GSS), Pluristem Therapeutics Inc. (NASDAQ:PSTI … (thestreetpoint.com) Pluristem Therapeutics Inc. (PSTI) moves -0.72% higher to SMA-50 (nasdaqplace.com)

    Pluristem Therapeutics stock traded up $0.01 during trading hours on Monday, reaching $1.37. The stock had a trading volume of 3,754 shares, compared to its average volume of 201,217. The firm has a market cap of $150.78 million, a PE ratio of -4.28 and a beta of 0.32. Pluristem Therapeutics has a 52 week low of $1.12 and a 52 week high of $2.12.

  • [By Stephan Byrd]

    Pluristem Therapeutics Inc. (NASDAQ:PSTI) has been given a consensus recommendation of “Buy” by the six brokerages that are presently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to the company. The average 1 year target price among brokers that have covered the stock in the last year is $4.00.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Pluristem Therapeutics (PSTI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Watch For 2019: Liberty Tax, Inc.(TAX)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Acacia Research (NASDAQ: ACTG) and Liberty Tax (NASDAQ:TAX) are both small-cap business services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, risk, earnings and valuation.

Top 10 Medical Stocks To Watch For 2019: TESARO, Inc.(TSRO)

Advisors’ Opinion:

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

  • [By Logan Wallace]

    TESARO Inc (NASDAQ:TSRO) Director Lawrence M. Alleva sold 7,142 shares of the firm’s stock in a transaction dated Tuesday, June 12th. The stock was sold at an average price of $43.11, for a total transaction of $307,891.62. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

  • [By Todd Campbell]

    Tesaro, Inc. (NASDAQ:TSRO) markets a highly successful therapy for ovarian cancer, Zejula, and its plans for the future include winning approval of Zejula’s use alongside another one of its drugs, TSR-042, in non-small cell lung cancer. Will this combination therapy reshape how oncologists treat lung cancer?

  • [By Paul Ausick]

    Tesaro Inc. (NASDAQ: TSRO) traded down more than 10% Wednesday and posted a new 52-week low of $44.51 after closing Tuesday at $49.63. The stock’s 52-week high is $168.92. Volume totaled around 3 million, approaching three times the daily average of around 1.1 million. European banks were hit hard by events in Italy, but Santander had no specific news.

  • [By Cory Renauer]

    All of these biotech stocks have been battered for different reasons, and bouncing back will be a lot easier for some than for others. 

    Company (Symbol) One-Month Loss  Market Capitalization
    Idera Pharmaceuticals (NASDAQ:IDRA) (35%) $199.7 million
    Spark Therapeutics (NASDAQ:ONCE) (38%) $2.16 billion
    Tesaro (NASDAQ:TSRO) (40%) $1.49 billion

    Here’s what needs to happen if these stocks are going to mount a comeback.

  • [By Ethan Ryder]

    TESARO (NASDAQ:TSRO)‘s stock had its “hold” rating reissued by stock analysts at Jefferies Financial Group in a report issued on Friday. They presently have a $38.00 price target on the biopharmaceutical company’s stock. Jefferies Financial Group’s price objective indicates a potential upside of 7.71% from the company’s current price.

Top 10 Medical Stocks To Watch For 2019: Quality Systems, Inc.(QSII)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Quality Systems (QSII)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Connor Clark & Lunn Investment Management Ltd. grew its position in shares of Quality Systems, Inc. (NASDAQ:QSII) by 493.0% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 82,275 shares of the company’s stock after purchasing an additional 68,400 shares during the quarter. Connor Clark & Lunn Investment Management Ltd. owned approximately 0.13% of Quality Systems worth $1,604,000 as of its most recent filing with the SEC.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Quality Systems (QSII)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

    Shares of Quality Systems, Inc. (NASDAQ: QSII) got a boost, shooting up 14 percent to $17.08 after the company posted better-than-expected FQ4 results.

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    Ross Stores, Inc. (NASDAQ: ROST) is projected to post quarterly earnings at $1.07 per share on revenue of $3.54 billion.
    Autodesk, Inc. (NASDAQ: ADSK) is expected to post quarterly earnings at $0.03 per share on revenue of $557.65 million.
    Gap, Inc. (NYSE: GPS) is projected to post quarterly earnings at $0.46 per share on revenue of $3.60 billion.
    Quality Systems, Inc. (NASDAQ: QSII) is estimated to post quarterly earnings at $0.13 per share on revenue of $131.95 million.
    Splunk Inc. (NASDAQ: SPLK) is expected to post quarterly loss at $0.09 per share on revenue of $297.67 million.
    Shoe Carnival, Inc. (NASDAQ: SCVL) is projected to post quarterly earnings at $0.71 per share on revenue of $262.02 million.
    Deckers Outdoor Corporation (NYSE: DECK) is expected to post quarterly earnings at $0.19 per share on revenue of $375.41 million.
    Zoe's Kitchen, Inc. (NYSE: ZOES) is estimated to post quarterly loss at $0.01 per share on revenue of $105.30 million.
    DXC Technology Company (NYSE: DXC) is expected to post quarterly earnings at $2.23 per share on revenue of $6.12 billion.
    8×8, Inc. (NASDAQ: EGHT) is estimated to post quarterly loss at $0.05 per share on revenue of $76.93 million.
    Viasat, Inc. (NASDAQ: VSAT) is projected to post quarterly loss at $0.45 per share on revenue of $424.46 million.
    ePlus inc. (NASDAQ: PLUS) is estimated to post quarterly earnings at $1.01 per share on revenue of $1.60 billion.
    Lions Gate Entertainment Corp. (NYSE: LGF.A) is expected to post quarterly loss at $0.04 per share on revenue of $1.04 billion.
    Agilysys, Inc. (NASDAQ: AGYS) is estimated to post quarterly loss at $0.08 per share on revenue of $32.58 million.
    Nutanix, Inc. (NASDAQ: NTNX) is estimated to post quarterly loss at $0.19 per share on revenue of $278.98 million.
    Veeva Systems Inc. (NYSE: VEEV) is projected to post quarterly earnings at $0.31 per share on revenue

Top 10 Medical Stocks To Watch For 2019: Ultralife Corporation(ULBI)

Advisors’ Opinion:

  • [By Shane Hupp]

    Polar Power (NASDAQ: POLA) and Ultralife (NASDAQ:ULBI) are both small-cap utilities companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends and valuation.

Top 10 Medical Stocks To Watch For 2019: HMS Holdings Corp(HMSY)

Advisors’ Opinion:

  • [By Max Byerly]

    Stock analysts at Chardan Capital initiated coverage on shares of HMS (NASDAQ:HMSY) in a report issued on Thursday, Marketbeat.com reports. The brokerage set a “neutral” rating and a $35.00 price target on the business services provider’s stock. Chardan Capital’s price target would indicate a potential upside of 3.67% from the stock’s current price.

  • [By Logan Wallace]

    HMS Holdings Corp (NASDAQ:HMSY) has earned an average recommendation of “Buy” from the eleven analysts that are currently covering the firm, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold recommendation, seven have given a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $30.13.

  • [By Shane Hupp]

    HMS Holdings Corp (NASDAQ:HMSY) has earned a consensus rating of “Buy” from the thirteen analysts that are presently covering the firm, MarketBeat.com reports. Three analysts have rated the stock with a hold recommendation, seven have assigned a buy recommendation and two have given a strong buy recommendation to the company. The average 1 year target price among brokers that have updated their coverage on the stock in the last year is $22.86.

  • [By Logan Wallace]

    Massachusetts Financial Services Co. MA increased its position in shares of HMS Holdings (NASDAQ:HMSY) by 40.9% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,007,174 shares of the business services provider’s stock after purchasing an additional 292,456 shares during the period. Massachusetts Financial Services Co. MA owned approximately 1.21% of HMS worth $16,961,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Max Byerly]

    Macquarie Group Ltd. raised its stake in shares of HMS Holdings Corp (NASDAQ:HMSY) by 344.4% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 8,000 shares of the business services provider’s stock after buying an additional 6,200 shares during the period. Macquarie Group Ltd.’s holdings in HMS were worth $173,000 as of its most recent SEC filing.

  • [By Lisa Levin] Gainers
    Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) shares jumped 29.86 percent to close at $2.87 on Friday.
    Commercial Vehicle Group, Inc. (NASDAQ: CVGI) shares gained 28.87 percent to close at $8.75 after reporting upbeat Q1 earnings.
    Mexco Energy Corporation (NYSE: MXC) gained 27.02 percent to close at $5.4744.
    Carbon Black, Inc. (NASDAQ: CBLK) climbed 26 percent to close at $23.94. Carbon Black priced its IPO at $19 per share.
    Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) rose 25.64 percent to close at $42.44 after the FDA approved the company's Andexxa, the only antidote indicated for patients treated with rivaroxaban and apixaban.
    Natural Grocers by Vitamin Cottage, Inc. (NYSE: NGVC) rose 23.19 percent to close at $8.50 after reporting Q2 results.
    California Resources Corporation (NYSE: CRC) shares gained 22.45 percent to close at $31.58 following upbeat Q1 earnings.
    Atomera Incorporated (NASDAQ: ATOM) gained 22.31 percent to close at $6.25 after reporting Q1 results.
    Medifast, Inc. (NYSE: MED) shares jumped 22.27 percent to close at $121.46 after the company reported strong Q1 results and raised its FY18 guidance.
    Jerash Holdings (US), Inc. (NASDAQ: JRSH) gained 20.86 percent to close at $8.46.
    Pandora Media, Inc. (NYSE: P) rose 19.83 percent to close at $6.89 after reporting strong quarterly results.
    Shake Shack Inc (NYSE: SHAK) rose 18.01 percent to close at $55.95 on Friday after the company reported upbeat results for its first quarter and raised its FY18 guidance.
    Super Micro Computer, Inc. (NASDAQ: SMCI) rose 17.73 percent to close at $21.25 after reporting strong preliminary results for the third quarter.
    Schmitt Industries, Inc. (NASDAQ: SMIT) rose 17.41 percent to close at $2.36.
    Titan International, Inc. (NYSE: TWI) shares gained 16.78 percent to close at $12.25 following Q1 earnings.
    Integer Holdings Corporation (NYSE: ITGR) shares rose 14.23 percent to close at $63.40 following Q1 result

Top 10 Medical Stocks To Watch For 2019: InspireMD, Inc.(NSPR)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Oragenics, Inc. (NYSE: OGEN) shares surged 66.67 percent to close at $2.00 on Wednesday after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study.
    Sigma Labs, Inc. (NASDAQ: SGLB) shares jumped 49.24 percent to close at $1.97 on Wednesday. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing.
    ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) rose 34.45 percent to close at $9.21. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating.
    Dick's Sporting Goods, Inc. (NYSE: DKS) shares rose 25.82 percent to close at $38.35 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook.
    TapImmune, Inc. (NASDAQ: TPIV) rose 24.15 percent to close at $5.09. WBB Securities upgraded TapImmune from Speculative Buy to Buy.
    Legacy Reserves LP (NASDAQ: LGCY) jumped 23.3 percent to close at $5.98 on Wednesday.
    Summer Infant, Inc. (NASDAQ: SUMR) gained 22.92 percent to close at $1.18 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital.
    Cloud Peak Energy Inc. (NYSE: CLD) rose 21.95 percent to close at $4.00.
    SpartanNash Co (NASDAQ: SPTN) gained 21.4 percent to close at $22.92 after the company reported upbeat earnings for its first quarter on Tuesday.
    Motus GI Holdings, Inc. (NASDAQ: MOTS) rose 17.14 percent to close at $5.40.
    Movado Group, Inc. (NYSE: MOV) gained 16.59 percent to close at $49.20 after the company reported better-than-expected Q1 results and raised its guidance.
    Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) climbed 15.61 percent to close at $8.22. Oramed Pharma disclosed that its patent has been allowed in the US for oral administration of proteins.
    Dorian LPG Ltd. (NYSE: LPG) rose 14.89 percent to close at $8.41. Dorian LPG confirmed receipt of unsolicited proposal fr
  • [By Lisa Levin] Gainers
    Sigma Labs, Inc. (NASDAQ: SGLB) shares rose 90.9 percent to $2.52. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing.
    Oragenics, Inc. (NYSE: OGEN) shares surged 58.4 percent to $1.9005 after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study.
    Dick's Sporting Goods, Inc. (NYSE: DKS) shares climbed 23.2 percent to $37.5370 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook.
    Summer Infant, Inc. (NASDAQ: SUMR) rose 21.9 percent to $1.17 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital.
    TapImmune, Inc. (NASDAQ: TPIV) jumped 18.8 percent to $4.87. WBB Securities upgraded TapImmune from Speculative Buy to Buy.
    Movado Group, Inc. (NYSE: MOV) gained 17.2 percent to $49.45 after the company reported better-than-expected Q1 results and raised its guidance.
    ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) jumped 16.2 percent to $7.96. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating.
    Legacy Reserves LP (NASDAQ: LGCY) rose 15.5 percent to $5.6011.
    InspireMD, Inc. (NYSE: NSPR) gained 13.3 percent to $1.36 following PR announcing sustained benefit of CGuard EPS.
    Immutep Limited (NASDAQ: IMMP) shares climbed 13.2 percent to $2.7724 after the company reported new data from its ongoing TACTI-mel Phase I trial, which evaluated the combination of eftilagimod alpha, its lead compound, with Merck & Co., Inc. (NYSE: MRK)'s Keytruda in unresectable or metastatic melanoma patients, who have had a suboptimal response or had disease progression with keytruda monotherapy..
    SpartanNash Co (NASDAQ: SPTN) rose 12.2 percent to $21.20 after the company reported upbeat earnings for its first quarter on Tuesday.
    Amtech Systems, Inc. (NASDAQ: ASYS) rose 12.1 percent to

Best High Tech Stocks To Invest In 2019

This year has been a pretty good one for energy stocks. Thanks to improving oil prices, the average energy stock as measured by the Vanguard Energy ETF (NYSEMKT: VDE) — which holds more than 140 energy stocks — is up about 6% for the year, outpacing the 4% gain for the S&P 500.

However, not all energy stocks have enjoyed an up year. Two of those laggards are TransCanada (NYSE:TRP) and Williams Companies (NYSE:WMB), which have both sold-off by double digits. Those declines have pushed their dividend yields above 5%, making them great options for income-focused investors to consider buying.

Image source: Getty Images.

Double-digit dividend growth at a double-digit discount

Despite getting off to a great start in 2018, shares of Williams Companies are down 10%. That sell-off doesn’t make sense given Williams’ improving financial profile and the growth it has coming down the pipeline.

Best High Tech Stocks To Invest In 2019: InspireMD, Inc.(NSPR)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Sigma Labs, Inc. (NASDAQ: SGLB) shares rose 90.9 percent to $2.52. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing.
    Oragenics, Inc. (NYSE: OGEN) shares surged 58.4 percent to $1.9005 after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study.
    Dick's Sporting Goods, Inc. (NYSE: DKS) shares climbed 23.2 percent to $37.5370 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook.
    Summer Infant, Inc. (NASDAQ: SUMR) rose 21.9 percent to $1.17 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital.
    TapImmune, Inc. (NASDAQ: TPIV) jumped 18.8 percent to $4.87. WBB Securities upgraded TapImmune from Speculative Buy to Buy.
    Movado Group, Inc. (NYSE: MOV) gained 17.2 percent to $49.45 after the company reported better-than-expected Q1 results and raised its guidance.
    ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) jumped 16.2 percent to $7.96. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating.
    Legacy Reserves LP (NASDAQ: LGCY) rose 15.5 percent to $5.6011.
    InspireMD, Inc. (NYSE: NSPR) gained 13.3 percent to $1.36 following PR announcing sustained benefit of CGuard EPS.
    Immutep Limited (NASDAQ: IMMP) shares climbed 13.2 percent to $2.7724 after the company reported new data from its ongoing TACTI-mel Phase I trial, which evaluated the combination of eftilagimod alpha, its lead compound, with Merck & Co., Inc. (NYSE: MRK)'s Keytruda in unresectable or metastatic melanoma patients, who have had a suboptimal response or had disease progression with keytruda monotherapy..
    SpartanNash Co (NASDAQ: SPTN) rose 12.2 percent to $21.20 after the company reported upbeat earnings for its first quarter on Tuesday.
    Amtech Systems, Inc. (NASDAQ: ASYS) rose 12.1 percent to
  • [By Lisa Levin] Gainers
    Oragenics, Inc. (NYSE: OGEN) shares surged 66.67 percent to close at $2.00 on Wednesday after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study.
    Sigma Labs, Inc. (NASDAQ: SGLB) shares jumped 49.24 percent to close at $1.97 on Wednesday. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing.
    ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) rose 34.45 percent to close at $9.21. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating.
    Dick's Sporting Goods, Inc. (NYSE: DKS) shares rose 25.82 percent to close at $38.35 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook.
    TapImmune, Inc. (NASDAQ: TPIV) rose 24.15 percent to close at $5.09. WBB Securities upgraded TapImmune from Speculative Buy to Buy.
    Legacy Reserves LP (NASDAQ: LGCY) jumped 23.3 percent to close at $5.98 on Wednesday.
    Summer Infant, Inc. (NASDAQ: SUMR) gained 22.92 percent to close at $1.18 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital.
    Cloud Peak Energy Inc. (NYSE: CLD) rose 21.95 percent to close at $4.00.
    SpartanNash Co (NASDAQ: SPTN) gained 21.4 percent to close at $22.92 after the company reported upbeat earnings for its first quarter on Tuesday.
    Motus GI Holdings, Inc. (NASDAQ: MOTS) rose 17.14 percent to close at $5.40.
    Movado Group, Inc. (NYSE: MOV) gained 16.59 percent to close at $49.20 after the company reported better-than-expected Q1 results and raised its guidance.
    Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) climbed 15.61 percent to close at $8.22. Oramed Pharma disclosed that its patent has been allowed in the US for oral administration of proteins.
    Dorian LPG Ltd. (NYSE: LPG) rose 14.89 percent to close at $8.41. Dorian LPG confirmed receipt of unsolicited proposal fr

Best High Tech Stocks To Invest In 2019: Bridgford Foods Corporation(BRID)

Advisors’ Opinion:

  • [By Max Byerly]

    Headlines about Bridgford Foods (NASDAQ:BRID) have been trending somewhat positive recently, according to Accern Sentiment. The research group scores the sentiment of press coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Bridgford Foods earned a daily sentiment score of 0.09 on Accern’s scale. Accern also gave media headlines about the company an impact score of 46.8333900378921 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

Best High Tech Stocks To Invest In 2019: Travelzoo Inc.(TZOO)

Advisors’ Opinion:

  • [By Max Byerly]

    Travelzoo (NASDAQ: TZOO) and CACI (NYSE:CACI) are both retail/wholesale companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, dividends, institutional ownership, profitability and valuation.

  • [By Lisa Levin]

    Shares of Travelzoo (NASDAQ: TZOO) got a boost, shooting up 30 percent to $10.16 following strong Q1 results.

    Six Flags Entertainment Corporation (NYSE: SIX) shares were also up, gaining 8 percent to $64.01 as the company posted a narrower-than-expected loss for its first quarter.

  • [By Lisa Levin] Gainers
    Daré Bioscience, Inc. (NASDAQ: DARE) shares climbed 54.2 percent to $1.25 on news that the company entered into worldwide license agreement for Juniper Pharmaceuticals' intravaginal ring technology platform.
    Travelzoo (NASDAQ: TZOO) climbed 21.3 percent to $9.40 following strong Q1 results.
    Intrepid Potash, Inc. (NYSE: IPI) gained 16.5 percent to $4.60.
    K12 Inc. (NYSE: LRN) shares rose 11.2 percent to $15.4206 following Q3 results.
    Chicago Bridge & Iron Company N.V. (NYSE: CBI) shares rose 11 percent to $15.3289. McDermott issued a release reiterating rejection of Subsea 7's offer.
    Six Flags Entertainment Corporation (NYSE: SIX) shares gained 9.2 percent to $64.61 as the company posted a narrower-than-expected loss for its first quarter.
    Tupperware Brands Corporation (NYSE: TUP) surged 8.5 percent to $46.00 as the company posted in-line quarterly earnings.
    Carlisle Companies Incorporated (NYSE: CSL) climbed 7.5 percent to $107.22 after reporting Q1 results.
    Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 6.1 percent to $14.78. B. Riley initiated coverage on Allena Pharmaceuticals with a Buy rating.
    Texas Instruments Incorporated (NASDAQ: TXN) rose 4.6 percent to $102.90 after the company reported stronger-than-expected earnings for its first quarter on Tuesday.
    Credit Suisse Group AG (NYSE: CS) rose 4.5 percent to $17.03 following strong Q1 results.
    STMicroelectronics N.V. (NYSE: STM) rose 4.2 percent to $22.20 after reporting Q1 results.

    Check out these big penny stock gainers and losers

Best High Tech Stocks To Invest In 2019: Marcus Corporation (MCS)

Advisors’ Opinion:

  • [By Stephan Byrd]

    McCarthy & Stone (LON:MCS) had its price target lowered by equities researchers at Deutsche Bank from GBX 189 ($2.52) to GBX 165 ($2.20) in a research report issued to clients and investors on Wednesday. The firm currently has a “buy” rating on the stock. Deutsche Bank’s target price would indicate a potential upside of 52.50% from the company’s current price.

  • [By Max Byerly]

    In other news, VP Thomas F. Kissinger sold 10,000 shares of Marcus stock in a transaction dated Wednesday, March 7th. The stock was sold at an average price of $29.12, for a total value of $291,200.00. Following the transaction, the vice president now owns 81,664 shares in the company, valued at $2,378,055.68. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Diane M. Gershowitz sold 12,750 shares of the firm’s stock in a transaction dated Friday, April 6th. The stock was sold at an average price of $30.86, for a total value of $393,465.00. Following the completion of the sale, the director now directly owns 7,482 shares in the company, valued at $230,894.52. The disclosure for this sale can be found here. Insiders have sold 44,250 shares of company stock valued at $1,343,255 in the last three months. 32.88% of the stock is owned by corporate insiders.

    ILLEGAL ACTIVITY WARNING: “Barrington Research Brokers Lower Earnings Estimates for Marcus Co. (MCS)” was originally published by Ticker Report and is owned by of Ticker Report. If you are viewing this piece of content on another site, it was illegally stolen and republished in violation of United States and international trademark & copyright legislation. The original version of this piece of content can be read at https://www.tickerreport.com/banking-finance/3367299/barrington-research-brokers-lower-earnings-estimates-for-marcus-co-mcs.html.

    Marcus Company Profile

  • [By Ethan Ryder]

    AMC Entertainment (NYSE: AMC) and Marcus (NYSE:MCS) are both consumer discretionary companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, earnings, profitability, analyst recommendations and risk.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Marcus (MCS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Marcus (NYSE: MCS) and AMC Entertainment (NYSE:AMC) are both consumer discretionary companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, earnings, analyst recommendations, valuation, dividends and institutional ownership.

Top 10 High Tech Stocks To Own For 2019

This article is reprinted by permission from NextAvenue.org.

A lot of news about cancer shines the spotlight on new and exciting drugs or treatments. Lost in the shuffle is something scientists have long known: lifestyle plays a big role in the prevention of many types of cancer.

Such a strong role, in fact, that a recent study in the journal JAMA Oncology suggests four key lifestyle habits not smoking, exercising regularly, keeping weight at a healthy level, and drinking in moderation could potentially cut cancer deaths in half. Thats right: 50% of all cancer deaths might be prevented with some simple changes in the way you eat, drink and live.

Top 10 High Tech Stocks To Own For 2019: GWG Holdings, Inc(GWGH)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on GWG (GWGH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 High Tech Stocks To Own For 2019: Calavo Growers, Inc.(CVGW)

Advisors’ Opinion:

  • [By Shanthi Rexaline]

    Agricultural Produce Companies

    Limoneira Company (NASDAQ: LMNR): -32.1 percent since 2011. Calavo Growers, Inc. (NASDAQ: CVGW): +168.2 percent since 2011.

    Agri-Input Companies — Seeds/ Fertilizers/Pesticides Manufacturers

  • [By Peter Graham]

    Small cap avocado and fresh food stock Calavo Growers (NASDAQ: CVGW) has elevated short interest of 33.51% according to Highshortinterest.com. Founded in 1924, Calavo Growers is a global avocado-industry leader and an expanding provider of value-added fresh food serving retail grocery, foodservice, club stores, mass merchandisers, food distributors and wholesalers worldwide. The Companys Fresh segment procures and markets fresh avocados and select other fresh produce (tomatoes) while the Renaissance Food Group segment (RFG) creates, markets and distributes a portfolio of healthy, fresh foods, including fresh-cut fruit, fresh-cut vegetables and prepared foods. The Foods segment manufactures and distributes guacamole and salsa. Fresh food products are sold under the respected Calavo brand name as well as Garden Highway, Chef Essentials and a variety of private label and store brands.

  • [By Lee Jackson]

    Calavo Growers Inc. (NASDAQ: CVGW) had the man at the top buying stock last week. CEO Lecil Cole purchased 95,000 shares of the avocados and other perishable foods distributor at prices between $55.44 and $56.92 a share. The total for the purchase was set at $5 million. The stock closed the day last Friday at $58.30, in a52-week range of$48.745 to $71.48. The consensus price target is set at $73.17.

Top 10 High Tech Stocks To Own For 2019: Discovery Communications, Inc.(DISCB)

Advisors’ Opinion:

  • [By Max Byerly]

    Discovery (NASDAQ:DISCB) announced its quarterly earnings results on Tuesday. The company reported $0.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.40 by $0.13, Morningstar.com reports. Discovery had a negative net margin of 7.40% and a positive return on equity of 19.34%. The company had revenue of $2.31 billion for the quarter.

Top 10 High Tech Stocks To Own For 2019: Xcel Energy Inc.(XEL)

Advisors’ Opinion:

  • [By Shauna O’Brien]

    Jefferies announced on Wednesday that it has raised its rating on Xcel Energy Inc (XEL).

    The firm has upgraded XEL from “Hold” to “Buy,” and has raised the company’s price target from $31 to $32.50. This new price target suggests a 15% upside from the stock’s current price of $27.72.

    Analyst Paul B. Fremont commented: “The stock is currently trading at an 8% P/E discount to our 2015E group average multiple.”

    “Despite a difficult political environment in Minnesota the company was able to achieve a reasonable outcome in its NSP-Minnesota rate case,” the analyst added.

    Looking forward, the firm has increased its FY2014 outlook from $1.95 to $2.00 per share.

    Xcel Energy shares were mostly flat during pre-market trading Wednesday. The stock has been mostly flat YTD.

  • [By Maxx Chatsko]

    The rise of wind power wouldn’t have been possible without two companies in particular, which combine to own 20.7 gigawatts of wind capacity, or about 24% of the country’s total. Investors wouldn’t be surprised to learn that clean energy provider NextEra Energy is one of the renewable energy stocks most important to American wind power.However, the relatively unheard of natural gas and electric utility Xcel Energy (NASDAQ:XEL) doesn’t seem to garner nearly the same level of attention. Overlooking it could be a mistake.

  • [By Joseph Griffin]

    Xcel Energy Inc (NYSE:XEL) has been assigned an average recommendation of “Buy” from the thirteen research firms that are currently covering the firm, MarketBeat Ratings reports. Five equities research analysts have rated the stock with a hold recommendation, seven have given a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year price objective among brokerages that have updated their coverage on the stock in the last year is $48.00.

Top 10 High Tech Stocks To Own For 2019: InspireMD, Inc.(NSPR)

Advisors’ Opinion:

  • [By Lisa Levin]

    InspireMD Inc (NYSE: NSPR) was down, falling around 35 percent to $1.29. InspireMD reported the pricing of public offering of up to $7.5 million.

    Commodities

Top 10 High Tech Stocks To Own For 2019: Allied Healthcare Products Inc.(AHPI)

Advisors’ Opinion:

  • [By Jim Robertson]

    Yesterday, our Under the Radar Moversnewsletter suggested shortingsmall cap respiratory equipmentstockAllied Healthcare Products Inc (NASDAQ: AHPI):

Top 10 High Tech Stocks To Own For 2019: Occidental Petroleum Corporation(OXY)

Advisors’ Opinion:

  • [By Ben Levisohn]

    We have seen several dividend cuts in the recent past, including Anadarko Petroleum cutting its dividend by 81%…and we expect more companies to follow suit. Chesapeake Energy (CHK), ConocoPhillips (COP), Encana,Marathon Oil and Noble Energy (NBL) are among energy companies that have also cut dividends in the past 12 months, but dividend requirements even after several cuts will consume ~26% of 2016 estimated cash flow at current dividend rates (15% excluding Occidental Petroleum (OXY)) for the large cap E&Ps we cover. We believe most of the companies with a dividend yield of more than 1.5% should consider cutting the dividend and find the following companies more likely than not to reduce dividends:Apache (2.5% yield),Devon Energy (4%),Encana (1.5%) andMarathon Oil (2.5%). We believe Canadian Natural Resource (CNQ) (3.0%) is likely to maintain its dividend while Occidental (4.5%) has the financial strength to maintain or even increase the dividend…

  • [By Chris Lange]

    Occidental Petroleum Corp.s (NYSE: OXY) short interest increased to 17.60 million shares from the previous reading of 15.53 million. Shares closed most recently at $66.90, in a 52-week range of $58.24 to $78.48.

  • [By Chris Lange]

    Occidental Petroleum Corp.s (NYSE: OXY) short interest decreased to 11.44 million shares from the previous reading of 11.77 million. Shares recently traded at $69.65, in a 52-week range of $57.20 to $78.09.

  • [By Chris Lange]

    Occidental Petroleum Corp.s (NYSE: OXY) short interest increased to 10.74 million shares from the previous reading of 9.91 million. Shares recently traded at $76.60, in a 52-week range of $57.20 to $78.09.

  • [By Chris Lange]

    Occidental Petroleum Corp.s (NYSE: OXY) short interest increased to 11.05 million shares from the previous reading of 10.74 million. Shares recently traded at $83.20, in a 52-week range of $57.84 to $84.28.

  • [By Garrett Cook]

    Citi notes that presentations from producers (the bank specifically notes Anadarko (NYSE: APC), Occidental Petroleum (NYSE: OXY), and Pioneer Natural Resources (NYSE: PXD)) showed a lack of commitment to enter 2017 hedge programs to lock in the economics for drilling.

Top 10 High Tech Stocks To Own For 2019: United Natural Foods, Inc.(UNFI)

Advisors’ Opinion:

  • [By Taylor Cox]

    Annual Shareholder Meetings

    United Natural Foods, Inc (NASDAQ: UNFI)
    Fireside Chat with Dan Gilbert and Kynikos Associates’ Jim Chanos 2 p.m. ET in Detroit

    IPOs

  • [By Stephan Byrd]

    Algert Global LLC bought a new stake in shares of United Natural Foods (NASDAQ:UNFI) during the 1st quarter, HoldingsChannel.com reports. The institutional investor bought 26,469 shares of the company’s stock, valued at approximately $1,137,000.

  • [By Peter Graham]

    The Q2 2017 earnings report for small cap natural andorganic foods stock United Natural Foods, Inc (NASDAQ: UNFI) is scheduled for after the market closes onWednesday (March 8th). United Natural Foods shares will tend to move in tandem with Whole Foods Market, Inc (NASDAQ: WFM) who accounts for more than 30% of sales.

Top 10 High Tech Stocks To Own For 2019: Progenics Pharmaceuticals Inc.(PGNX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) shares shot up 29 percent to $6.37 after announcing the FDA approval of RELISTOR tablets for the treatment of opioid-induced constipation in adults with chronic non-cancer pain.

  • [By Ben Levisohn]

    After meeting with the senior management team of Progenics (PGNX) , Valeant’s partner for oral Relistor, we continue to think that this drug would be a good addition to Valeant’s GI (gastrointestinal) franchise. The PDUFA date for oral Relistor is 7/19/16. AlthoughValeant is leading interactions with the FDA, Progenics is highly confident regarding an approval in July based on its discussions with Valeant. Progenics believes that oral Relistor could be a $1B+ opportunity for Valeant, even with the recent decrease in opioid usage. For context, we estimate ’16 sales of $9.9B for Valeant. An approval for oral Relistor would also help remind the Street that Valeant’s brand drug pipeline is underappreciated, in our view. We think pipeline advancements for brand drugs could drive multiple expansion forValeant shares (on P/E).

Top 10 High Tech Stocks To Own For 2019: Beneficial Mutual Bancorp Inc.(BNCL)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Media coverage about Beneficial Bancorp (NASDAQ:BNCL) has trended positive recently, according to Accern. Accern identifies positive and negative news coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Beneficial Bancorp earned a news impact score of 0.38 on Accern’s scale. Accern also gave media headlines about the bank an impact score of 45.8699493506664 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

Top 5 Blue Chip Stocks To Watch For 2018

Periodically we update you on our latest best stocks to buy now – stocks our experts have named good buys. This edition brings you five picks that have an established track record and also give you access to the most exciting new trends of the future. So they can provide profits for years – even generations – to come.

First, a company that started with a broken saw blade and a plow is now a world leader in next-generation vehicles. Then, one of the most trusted makers of outdoor apparel is unfazed by industry headwinds. Next, one of our favorite plays on legal marijuana is not a small startup but a 150-year-old gardening blue chip. Then, as America rebuilds after hurricane season, we look at a company providing one of the Earth’s most versatile materials. And finally, we highlight an ETF that manages to get you in on the ground floor of new IPOs while offering safety and consistent performance.

Here are our five latest best stocks to buy now…

Top 5 Blue Chip Stocks To Watch For 2018: Allstate Corporation (ALL)

Advisors’ Opinion:

  • [By Shauna O’Brien]

    Credit Suisse reported on Thursday that it has raised its estimates on insurance company The Allstate Corporation (ALL).

    The firm has raised its price target on ALL to $62. This price target suggests a 16% upside from the stock’s current price of $52.23. Analysts currently have an “Outperform” rating on ALL.

    Credit Suisse has also boosted estimates on ALL as its management is increasing returns.

    Allstate shares were up 32 cents, or 0.62%, during Thursday morning trading. The stock is up 30% YTD.

  • [By Anders Bylund, Chuck Saletta, and Brian Feroldi]

    Read on to see why they pickedAllstate(NYSE:ALL),EPAM Systems(NYSE:EPAM), andUniversal Display(NASDAQ:OLED).

    Image source: Getty Images.

  • [By Michael Flannelly]

    Wells Fargo analysts see a number of upside catalysts for The Allstate Corporation (ALL), plus a positive trend for automobile insurers as a whole. As such, the analysts upgraded the insurance provider on Thursday.

    The analysts upgraded ALL from “Market Perform” to “Outperform” and boosted its valuation range from $48-$52 to $58-$62. This new valuation range suggests a 16% to 24% upside to the stock’s Wednesday closing price of $50.11.

    “We are upgrading the shares of Allstate to Outperform from Market Perform on the basis of several fundamental reasons unique to the company as well as several positive, emerging structural trends for auto insurers in general,” Wells Fargo analyst John Hall stated. “We do not believe that the market has yet paid for potential unit growth within Allstate’s branded standard book of auto insurance, something we envision occurring over the next 6-12 months.”

    As for some of the positive personal auto insurance sector trends, Hall noted, “These would include shifting demographics toward a safer driving population mix (more old drivers and fewer young drivers), changing driving habits particularly among millennials, a safer U.S. personal auto fleet, rising car sales pointing to positive symbol shift as well as industry conditions encouraging market share consolidation.”

    Wells Fargo boosted Allstate’s 2013 EPS estimates from $4.62 to $4.85 and 2014 EPS estimates from $4.85 to $5.20.

    Allstate shares were mostly flat during pre-market trading on Thursday. The stock is up 24.74% year-to-date.

Top 5 Blue Chip Stocks To Watch For 2018: Transcananda Pipelines Ltd.(TRP)

Advisors’ Opinion:

  • [By Ben Levisohn]

    In a number of articles recently, following the US recent revival and potential approval of the previously blocked Keystone XL pipeline, a number of estimates have been provided suggesting a pending boom for the US steel industry is on the horizon (and US steel stocks have reacted in kind). In fact, this optimism, we believe, peaked today when a report from one of our competitors was published claiming that, the keystone XL pipeline could increase line pipe demand by 14.7% for 2 years. The problem here, we believe, rests with the facts that: (a) TransCanada (TRP) has already taken, and paid for, the steel to build the Keystone XL pipeline (the steel currently sits in storage facilities in both Regina, Canada and Arkansas, United States), (b) neither US Steel (X; SELL), AK Steel, Steel Dynamics, or Nucor have the ability to make the specialized steel required for the miles of pipe associated with this project, to include both the thickness and pressure requirements, according to this article from Reuters, and (c) assuming some of the pipe does need replacement, this would likely come from international steel makers who are capable of producing the specialized steel (again, as highlighted in this Reuters article).

  • [By Paul Ausick]

    That includes pipeline companies like Kinder Morgan Inc. (NYSE: KMI), which already operates a pipeline transporting natural gas from Texas into Mexico, and master limited partnerships (MLPs) Energy Transfer Partners L.P. (NYSE: ETP) and TransCanada Corp. (NYSE: TRP), the company that has (so far) failed to get U.S. approval for its Keystone Pipeline expansion from Canada’s oil sands across the U.S. border.

  • [By Matthew DiLallo]

    After a series of setbacks in its attempts to build new oil pipelines, Canadian pipeline giant TransCanada (NYSE:TRP) completed a transformation transaction to acquire U.S. natural gas pipeline company Columbia Pipeline Group for $13 billion, which includes the assumption of debt. The key to that deal was that it increased the combined company’s near-term project pipeline to 23 billion Canadian dollars, which supports TransCanada’s ability to increase its dividend by 8% to 10% annually through 2020. After completing that deal, TransCanada made a bid to acquire all of the outstanding units that it did not own of affiliated MLP Columbia Pipeline Partners (NYSE:CPPL) in a transaction valued at $915 million. These acquisitions solidified TransCanada’s natural gas pipeline growth ambitions, enabling it to diversify away from oil pipelines.

  • [By Matthew DiLallo]

    Most investors have probably heard of energy giants Royal Dutch Shell (NYSE:RDS-A) (NYSE:RDS-B), Dominion Energy (NYSE:D), and TransCanada (NYSE:TRP). Fewer, however, are likely familiar with their publicly traded master limited partnerships (MLPs): Shell Midstream Partners (NYSE:SHLX), Dominion Energy Midstream Partners (NYSE:DM), and TC Pipelines (NYSE:TCP). That might be a good thing, as the market has beaten up the latter trio this year, sending their valuations south.

  • [By Matthew DiLallo]

    Energy infrastructure companies ONEOK (NYSE:OKE) and TransCanada (NYSE:TRP) are both emerging from the energy market downturn as stronger entities. Each made smart acquisitions, with TransCanada buying U.S. gas pipeline company Columbia Pipeline Group, while ONEOK is in the process of gobbling up its MLP,ONEOK Partners (NYSE:OKS). While these deals enhanced the growth profiles of both companies, TransCanada still stands out as the better buy for long-term income investors. Here’s why.

  • [By Paul Ausick]

    In addition to the Trans Mountain system, two other pipeline projects currently are proposed to move crude oil from Alberta either to the Great Lakes or the Gulf Coast. Enbridge Inc. (NYSE: ENB) is proposing to replace its 50-year old Line 3 system to transport 760,000 barrels a day to Superior, Wisconsin. TransCanada Corp. (NYSE: TRP) has received approval from the Trump administration and would transport 830,000 barrels a day to Nebraska where existing pipelines will take over, sending the crude to U.S. refineries and Gulf Coast terminals.

Top 5 Blue Chip Stocks To Watch For 2018: InspireMD, Inc.(NSPR)

Advisors’ Opinion:

  • [By Lisa Levin]

    InspireMD Inc (NYSE: NSPR) was down, falling around 35 percent to $1.29. InspireMD reported the pricing of public offering of up to $7.5 million.

    Commodities

Top 5 Blue Chip Stocks To Watch For 2018: Zillow Group, Inc.(Z)

Advisors’ Opinion:

  • [By Anders Bylund]

    Shares of Zillow Group (NASDAQ:Z) (NASDAQ:ZG) fell hard on Friday morning. Class A shares fell as much as 11.1% and the non-voting Class C stock dropped 10.4% lower at most. As of 3 p.m. EDT, both stock classes had recovered somewhat to a daily loss of approximately 7.5%.

  • [By Steve Symington]

    The stock market was mostly flat today ahead of a key House vote on the passage of the Republicans’ healthcare bill, which was delayed until Friday after GOP lawmakers failed to gather the necessary support. TheDow Jones Industrial Averagelost just 5 points, or 0.02%, while other broader market indexes saw similar small declines. But several individual stocks saw much more severe drops, including Zillow Group (NASDAQ:Z) (NASDAQ:ZG), Proofpoint (NASDAQ:PFPT), and Accenture (NYSE:ACN). Read on to see what drove these unusual moves.

  • [By Nelson Hem]

    Also in this week’s Barron’s:

    A special report on strategic beta ETFs How to take advantage of underpriced stocks Who is in denial about the death of the personal computer market Finding the best value mutual funds Finding value in big stocks and emerging markets How mining companies are striving for sustainability Why Zillow Group, Inc.-Class C (NASDAQ: Z) could fall 25 percent Six unconventional yield plays for an uncertain market Why Alibaba Group Holding Ltd (NYSE: BABA) investors may lose in hot IPO

    Disclosure: At the time of this writing, the author had no position in the mentioned equities.

  • [By Steve Symington]

    Shares of Zillow Group Inc. (NASDAQ:Z)(NASDAQ:ZG)climbed 13.8% in the month of April,according to data provided byS&P Global Market Intelligence, ahead of the online real estate specialist’s impending first-quarter 2017 report.

  • [By Motley Fool Staff]

    Zillow Group (C shares) (NASDAQ:Z) Q1 2018 Earnings Conference CallMay. 7, 2018 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Paul Ausick]

    After markets closed on Monday, rental car company Hertz Global Holdings Inc. (NYSE: HTZ) and real-estate firm Zillow Group Inc. (NASDAQ: Z) reported quarterly results. Before markets opened Tuesday morning Discovery Inc. (NASDAQ: DISCA) and Dish Network Corp. (NASDAQ: DISH) also released earnings reports. Here’s a quick look at the reports and the reactions to them.

Top 5 Blue Chip Stocks To Watch For 2018: Brookfield Renewable Powerr Fund(BEP)

Advisors’ Opinion:

  • [By Timothy Green, Matthew DiLallo, and Nicholas Rossolillo]

    Of course, holding on to the wrong stock for decades can be disastrous, so it’s critical that you’re picky about your long-term investments. If you’re short on ideas, three of our contributors think Brookfield Renewable Partners (NYSE:BEP), Berkshire Hathaway (NYSE:BRK.B), and Booking Holdings (NASDAQ:BKNG) are fantastic options.

  • [By Federico Zaldua]

    I expect the Brookfield Group of Companies, which is composed of no fewer than 15 publicly traded entities, to be very active acquisitive in the near-term future. Here I focus my attention on three members of the Brookfield Group that are going to be the most active with M&A. While Brookfield Asset Management (BAM) will concentrate its M&A efforts into all geographies and all asset classes, Brookfield Renewable Energy Partners (BEP) and Brookfield Infrastructure Partners (BIP) will concentrate on their respective industries. Let’s see whether you should go long on any of this separate -although related – entities.

    Good Operational Performance

    Brookfield Asset Management, held by Lou Simpson and Ron Baron, counts with a liquidity position of more than $5 billion at the parent and principal subsidiaries along with nearly $10 billion drawable private fund commitments. More importantly, the company has expressed its interest into using this liquidity to make acquisitions. Management clearly stated in its letter to shareholders:

  • [By Tyler Crowe, Leo Sun, and Brian Feroldi]

    With this in mind, we asked three of our Fool.com contributors to highlight a stock they consider a great dividend stock for someone in retirement. Here’s why they picked Starbucks (NASDAQ:SBUX), Verizon Communications (NYSE:VZ), and Brookfield Renewable Partners (NYSE:BEP).

  • [By Tyler Crowe, Reuben Gregg Brewer, and Travis Hoium]

    With these interesting trends emerging, there’s no doubt that investors are looking at this industry. To help investors start their search for great energy investments, we asked three of our investing contributors to each highlight a stock they see as a great buy now. Here’s why they picked Magellan Midstream Partners (NYSE:MMP), Brookfield Renewable Partners (NYSE:BEP), and SunPower (NASDAQ:SPWR).

  • [By Neha Chamaria]

    Right now, I believe Mastercard (NYSE:MA), Brookfield Renewable Partners(NYSE:BEP), and XPO Logistics(NYSE:XPO) fall right into place, because each stock has been a multibagger and has strong tailwinds behind it.

Top 10 Safest Stocks To Watch For 2018

Every night in 1995, I would deposit money overnight in a different currency…   Sounds strange, I realize.   But back then, as the vice president of a global mutual fund, one of my jobs was to execute our fund's trades.   Once our U.S. trading day was done, we wanted our money to work for us overnight as well. We might put our money into French francs, German marks, or somewhere else – just for the night.   We would find the safest country that was paying the highest interest rate. And we would put our money there overnight. No kidding.   As I'll explain today, what we were doing wasn't anything special…   Big companies like German automaker Volkswagen and Japanese automaker Honda (and thousands of other companies) have cash-management departments that do basically the same thing – on a much larger scale.

Top 10 Safest Stocks To Watch For 2018: The Kraft Heinz Company(KHC)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Susquehanna’s Pablo Zuanic and team note that Keurig’s business in K-cups has been slowing ever since it was bought by JAB, a problem that could be solved in a very convoluted way by a Mondelez International (MDLZ)-Kraft Heinz (KHC) merger. They explain:

  • [By Bradley Seth McNew]

    Shares ofThe Kraft Heinz Company(NASDAQ:KHC) rose 20% in 2016, according to data provided byS&P Global Market Intelligence. Iconic snack and food product brands Kraft and Heinz merged in 2015, and shares grew in 2016 as the newly merged company reported solid earnings growth throughout the year.

  • [By Paul Ausick]

    The Kraft Heinz Co. (NASDAQ: KHC) fell about 7% Friday to post a new 52-week low of $67.65 after closing at $72.71 on Thursday. The 52-week high is $97.77. Volume of about 12.8 million was more than three times the daily average. The food processing company reported poor earnings this morning and suggested that sales could get worse as competition increases. https://247wallst.com/consumer-products/2018/02/16/how-kraft-heinz-earnings-fell-short/

Top 10 Safest Stocks To Watch For 2018: Apollo Global Management, LLC(APO)

Advisors’ Opinion:

  • [By Paul Ausick]

    Reuters reported last week that the company is considering selling its 2,500 service stations in Italy for a tidy 500 million (about $538 million). The rumored buyer is private equity giant Apollo Global Management LLC (NYSE: APO), also rumored to be interested in buying 2,600 Italian service stations from a joint venture between Italy’s Eni SpA (NYSE: E) and Total SA (NYSE: TOT).

  • [By Peter Graham]

    The Q1 2017 earnings report for small cap for-profit education stock Apollo Education Group Inc (NASDAQ: APOL) is scheduled for after the market closes on Monday (January 9th). Last February, Apollo Education Groupannounced a definitive agreement to be acquired by a consortium of investors including The Vistria Group, LLC, funds affiliated with Apollo Global Management, LLC (NYSE: APO), and Najafi Companies for $9.50 per share in cash for both Class A and B shares. However, the for-profit education sector along with certain aspects of the Apollo deal have been targeted by the Obama administration and it remains to be seen how the Trump administration will treat the sector and the deal.

  • [By Peter Graham]

    A long term performance chart shows shares of Netflix close to all time highsgoing into earnings while potential performance peer or competitor Amazon.com, Inc (NASDAQ: AMZN) has continueda more steadyrise and small cap Outerwall Inc (NASDAQ: OUTR), which owned the Redbox business,got swallowed up Apollo Global Management, LLC (NYSE: APO) late last year:

Top 10 Safest Stocks To Watch For 2018: Ocean Power Technologies Inc.(OPTT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Ocean Power Technologies Inc (NASDAQ: OPTT) shares shot up 44 percent to $2.64. On Friday, Ocean Power Technologies reported the deployment of its PB3 PowerBuoy in Japan.

Top 10 Safest Stocks To Watch For 2018: Fox Factory Holding Corp.(FOXF)

Advisors’ Opinion:

  • [By Javier Hasse]

    Fox Factory Holding Corp (NASDAQ: FOXF) was down 1.8 percent after posting a 2.16 percent rise over the day.

    Finally, Groupon Inc (NASDAQ: GRPN) gained 1.3 percent, continuing with the 3.85 percent spike it experienced on Friday trading.

Top 10 Safest Stocks To Watch For 2018: Zion Oil & Gas Inc(ZN)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Zion Oil & Gas, Inc. (NASDAQ: ZN) got a boost, shooting up 20 percent to $5.07.

    Spark Energy Inc (NASDAQ: SPKE) shares were also up, gaining 12 percent to $19.40. Guggenheim upgraded Spark Energy from Neutral to Buy.

  • [By Lisa Levin]

    In trading on Wednesday, energy shares fell by 0.76 percent. Meanwhile, top losers in the sector included Whiting Petroleum Corp (NYSE: WLL), down 6 percent, and Zion Oil & Gas, Inc. (NASDAQ: ZN) down 7 percent.

  • [By Lisa Levin]

    Shares of Zion Oil & Gas, Inc. (NASDAQ: ZN) got a boost, shooting up 47 percent to $6.21.

    Spark Energy Inc (NASDAQ: SPKE) shares were also up, gaining 10 percent to $19.10. Guggenheim upgraded Spark Energy from Neutral to Buy.

Top 10 Safest Stocks To Watch For 2018: Gerdau S.A.(GGB)

Advisors’ Opinion:

  • [By Manikandan Raman]

    On the news, Freeport-McMoRan surged 12 percent to $10.20 and Lundin Mining climbed 12 percent to $3.33. Gerdau SA (ADR) (NYSE: GGB) rose 19 percent to $1.23, Vale SA (ADR) (NYSE: VALE) advanced 18 percent to $4.85 and Banco Bradesco SA (ADR) (NYSE: BBD) gained 11 percent to $7.15.

Top 10 Safest Stocks To Watch For 2018: Monotype Imaging Holdings Inc.(TYPE)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Monotype Imaging Holdings Inc. (NASDAQ: TYPE) were down around 12 percent to $20.90 after the company posted downbeat quarterly earnings.

  • [By Lisa Levin]

    Wednesday afternoon, the non-cyclical consumer goods & services shares surged 0.61 percent. Meanwhile, top gainers in the sector included Monotype Imaging Holdings Inc. (NASDAQ: TYPE), up 9 percent, and Semiconductor Manufacturing Int'l (ADR) (NYSE: SMI), up 6 percent.

Top 10 Safest Stocks To Watch For 2018: InspireMD, Inc.(NSPR)

Advisors’ Opinion:

  • [By Lisa Levin]

    InspireMD Inc (NYSE: NSPR) was down, falling around 35 percent to $1.29. InspireMD reported the pricing of public offering of up to $7.5 million.

    Commodities

Top 10 Safest Stocks To Watch For 2018: 3M Company(MMM)

Advisors’ Opinion:

  • [By Paul Ausick]

    3M Company (NYSE: MMM) traded up 0.8% at $196.10. The stock’s 52-week range is $191.44 to $259.77. Volume was about 15% below the daily average of around 3 million. The company had no specific news Thursday.

  • [By Ben Levisohn]

    Second, how will the Dow get to that big magic number? Well, the six biggest stock weightings in the DJIA are: Goldman Sachs (GS), 3M (MMM), International Business Machines (IBM), UnitedHealth Group (UNH), and Boeing (BA). What you will notice looking at a day like yesterday is that tech led the way sector wise. If the Dow is going to outperform, we need mega caps to outperform. We need those six stocks to outperform. So we need a day where financials and industrials outperform to get there. Given the trends in sector leadership, that is bound to happen…We are one Trump tweet talking about how yuuuuuuge Goldman Sachs is away from 20k.

  • [By Dustin Blitchok]

    Morrison’s resignation came about one hour after 3M Co (NYSE: MMM) CEO Inge Thulin pulled the plug.

    In a Wednesday statement on his departure from what’s formally known as the Manufacturing Jobs Initiative, Thulin said the group “is no longer an effective vehicle” for the technology company to promote job growth in the U.S.

  • [By ]

    It’d be one thing if GE were cheap, but on many metrics, it’s not. Many investors at this point would rather pay for United Technologies Corporation (UTX)  , Honeywell International Inc. (HON)  or 3M Co (MMM)  — the last two of which are holdings in Jim Cramer’s Action Alerts PLUS Charitable Trust Portfolio.

  • [By Chris Lange]

    3M Co. (NYSE: MMM) is set to report its most recent quarterly results on Tuesday. Analysts are looking for $5.57 in earnings per share (EPS) and $8.69 billion in revenue. Shares closed the week at $217.75, with a consensus price target of $237.92 and a 52-week trading range of $190.59 to $259.77.

Top 10 Safest Stocks To Watch For 2018: iAnthus Capital Holdings, Inc. (ITHUF)

Advisors’ Opinion:

  • [By Javier Hasse]

    Over the past few weeks, Benzinga has been sharing interviews with the top venture capital and investment firms operating in the cannabis industry. Among those focused on ancillary businesses that do not touch the plant, we profiled Snoop Dogg’s Casa Verde and Arcview Group partner, CanopyBoulder. Among those willing to get involved in plant-touching ventures, we presented MJIC, which claims it intends to become the “Amazon.com, Inc. (NASDAQ: AMZN) of weed,” and iAnthus Capital Holdings Inc (CNSX: IAN) (OTC: ITHUF), which raises capital for U.S.-based marijuana companies in Canadian capital markets.

  • [By ]

    Much of the focus of cannabis investors has been centered on Canada and California. This makes sense given that they are the two largest recreational (or soon to be) cannabis markets in the world. However, one publicly traded company with US-centric cannabis operations has taken a different approach. iAnthus Capital is listed in Canada on the CSE (OTCQB:ITHUF), but is headquartered in New York and incorporated in Delaware. Unlike other Canadian-listed cannabis companies, most of which are aiming to get in on the highly competitive green-rush in California and Canada, iAnthus has set its sights on becoming the dominant player on the U.S. East Coast.

  • [By Javier Hasse]

    Earlier this month, cannabis-focused financing and advisory firm iAnthus Capital Holdings Inc (CNSX: IAN) (OTC: ITHUF) announced it acquired Westchester-based Valley Agriceuticals, LLC, gaining access to New York’s nascent cannabis market.

  • [By Javier Hasse]

    The Green Solution received a $7.5 million loan facility from iAnthus Capital Holdings Inc (OTC: ITHUF).

    “This was also to accelerate expansion within Colorado and going into other states nation-wide.”

    Valens Groworks Corp (CNSX: VGW), a Canadian post-inspection applicant for cannabis cultivation and processing, raised C$500,000 ($381,431) under a convertible note to meet acquisition and expansion obligations.

Best Dividend Stocks To Watch For 2018

When it comes to safe stocks, there may be none safer than healthcare conglomerate Johnson & Johnson (NYSE:JNJ). Johnson & Johnson is often a staple holding for income seekers, conservative investors, and even value investors. It has a 54-year streak of increasing its dividend payout, which should almost certainly become 55 years come April, and it’s one of two remaining publicly listed companies with a “AAA” credit rating from Standard & Poor’s. That’s a higher credit rating than the U.S. government.

The secret to J&J’s long-term success has been its business structure. Instead of operating as one giant company, it’s composed of more than 250 subsidiaries, which allows management to play with the dominoes, if you will, from time to time, in order to boost growth. It’s been able to divest slower-growing assets and acquire pharmaceutical products in recent years to boost its near- and intermediate-term growth prospects. Pharma is, without question, the largest contributor to its gross margin and top- and bottom-line growth.

Best Dividend Stocks To Watch For 2018: Aimmune Therapeutics, Inc.(AIMT)

Advisors’ Opinion:

  • [By Chris Lange]

    Aimmune Therapeutics Inc. (NASDAQ: AIMT) is looking for Phase 3 data for in its Palisade trial of AR101 in February. Specifically, this trial is looking to treat peanut allergies. Shares closed most recently at $36.18, with a consensus price target of $57.38 and a 52-week range of $15.97 to $40.65.

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

  • [By Jim Robertson]

    Small cap clinical-stage biopharmaceutical stock Aimmune Therapeutics (NASDAQ: AIMT) is aclinical-stage biopharmaceutical company developing treatments for life-threatening food allergies. The Companys Characterized Oral Desensitization ImmunoTherapy (CODIT) approach is intended to achieve meaningful levels of protection by desensitizing patients with defined, precise amounts of key allergens. Aimmune Therapeutics first investigational biologic product using CODIT⒙is AR101 for the treatment of peanut allergy.AR101 has received the FDAs Breakthrough Therapy Designation for the desensitization of peanut-allergic patients 4-17 years of age and is currently being evaluated in Phase 3 clinical trials where enrollment was announced last month.

  • [By Chris Lange]

    Aimmune Therapeutics Inc. (NASDAQ: AIMT) is looking for Phase 3 data for in its Palisade trial of AR101 in February. Specifically, this trial is looking to treat peanut allergies. Shares closed trading most recently at $37.13, with a consensus price target of $55.50 and a 52-week range of $15.97 to $40.65.

Best Dividend Stocks To Watch For 2018: Carnival Corporation(CCL)

Advisors’ Opinion:

  • [By Chris Lange]

    Carnival Corp. (NYSE: CCL) fiscal first-quarter report is scheduled for Thursday. The consensus forecast is $0.43 in EPS on $4.11 billion in revenue. Shares closed at $66.91 apiece. The consensus price target is $76.94, and the 52-week range is $57.09 to $72.70.

  • [By Rick Munarriz]

    Carnival Corporation & plc (NYSE:CCL) (NYSE:CUK)shareholders have to be feeling pretty good these days. The stock hit yet another new high on Friday, and the stock is trading 13% higher so far in 2017.It’s been smooth sailing so far this year, but the first big test comes on Tuesday morning when the world’s largest cruise line operator reports financial results for its fiscal first quarter.

  • [By WWW.THESTREET.COM]

    How about individual stories? Tuesday I was pleasantly surprised by the commentary on both the Darden (DRI) and Carnival (CCL) calls. Weekend dining and lunch were very strong for Darden, parent of Olive Garden, even though CEO Gene Lee acknowledged that it’s competing against “new necessities today, whether smartphones, whether it’s your cable bill, your Netflix bill. I mean, they have increased significantly over the years.” Hmm, is there any wonder why takeout pizza is so strong? Makes me want to buy both Darden and Domino’s (DPZ) .

Best Dividend Stocks To Watch For 2018: InspireMD, Inc.(NSPR)

Advisors’ Opinion:

  • [By Lisa Levin]

    InspireMD Inc (NYSE: NSPR) was down, falling around 35 percent to $1.29. InspireMD reported the pricing of public offering of up to $7.5 million.

    Commodities

Best Value Stocks To Own For 2018

source: Turquoise Hill website

For some time the share price of Turquoise Hill (TRQ) has been floundering around, as demand for copper has been restrained, as well as gold, which is the secondary metal it mines for.

That combination has keep the share price of the miner at a little over $3.00 per share for some time. That appears to have changed as the price of copper appears to have found a bottom and demand from China will likely continue to increase over the next 12 months at least.

The market is just starting to reward Turquoise Hill for the strength in copper, with the company soaring in value since the first week of December.

Best Value Stocks To Own For 2018: Abbott Laboratories(ABT)

Advisors’ Opinion:

  • [By Matt Hogan]

    AbbVie has distributed a significant amount of its earnings in the form of dividends (~60 percent) since the company spun off from Abbott Laboratories (NYSE: ABT) in 2013. The company appears to be trading at a 10 percent discount to fair value when applying similar assumptions in the 5-year dividend discount model as shown below.

  • [By Sean Williams]

    Finally, and as the icing on the cake, Wall Street uncovered via a Securities and Exchange Commission filing that Abbott Laboratories (NYSE:ABT) sold 44 million shares of Mylan stock at $41.60, reducing its remaining position in the company to 25.75 million shares, or about 4.8% of its outstanding shares. Considering all the issues Mylan has had recently, the fact that Abbott substantially pared its large holding in the company is a bit worrisome.

  • [By WWW.THESTREET.COM]

    In the Lightning Round, Cramer was bullish on Abbott Laboratories (ABT) , Dycom Industries (DY) and Howard Hughes (HHC) .

    Cramer was bearish on Headwaters (HW) , EnergySolutions (ES) , Western Refining (WNR) and Horizon Pharmaceuticals (HZNP) .

Best Value Stocks To Own For 2018: InspireMD, Inc.(NSPR)

Advisors’ Opinion:

  • [By Lisa Levin]

    InspireMD Inc (NYSE: NSPR) was down, falling around 35 percent to $1.29. InspireMD reported the pricing of public offering of up to $7.5 million.

    Commodities

Best Value Stocks To Own For 2018: AAON Inc.(AAON)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Aaon Inc. (AAON) is an Oklahoma-based, family-owned and operated firm, with 23.54% insider ownership. It is an excellent business to own for the long term.

Best Value Stocks To Own For 2018: Cimpress N.V(CMPR)

Advisors’ Opinion:

  • [By Steve Symington]

    Shares ofCimpress NV(NASDAQ:CMPR)climbed 14.6% in 2016,according to data from S&P Global Market Intelligence, as the mass customization specialist steadfastly pursued its novel long-term efforts to generate shareholder value.

Best Value Stocks To Own For 2018: Aerohive Networks, Inc.(HIVE)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Aerohive Networks Inc (NYSE: HIVE) were down 33 percent to $3.10. Aerohive Networks reported a Q2 loss of $3.9 million on revenue of $42.3 million, and disclosed that it has extended its $10 million buyback plan.

  • [By Monica Gerson]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Citigroup Inc (NYSE: C) to report quarterly earnings at $1.16 per share on revenue of $17.34 billion before the opening bell. Citigroup shares rose 0.47 percent to $48.70 in after-hours trading.
    HP Inc (NYSE: HPQ) disclosed that it would be implementing a restructuring plan that would likely result in the firing of 3,000 to 4,000 employees, annual savings of $200 million to $300 million, and a charge of $350 million to $500 million. Management also announced a 7 percent surge in the stock’s dividend and an additional $3 million share repurchase program. The company issued its outlook for fiscal 2017, guiding for EPS of $1.55 to $1.65, mostly below the Street’s consensus of $1.64. HP shares fell 1.32 percent to $14.95 in the after-hours trading session.
    Analysts are expecting JPMorgan Chase & Co. (NYSE: JPM) to have earned $1.39 per share on revenue of $23.99 billion in the latest quarter. JPMorgan will release earnings before the markets open. JPMorgan shares gained 0.37 perecent to $67.99 in after-hours trading.
    Aerohive Networks Inc (NYSE: HIVE) reported weak preliminary results for its third quarter. The company said it expects a net loss of $(0.06) to $(0.07) per share, versus consensus at $(0.04) per share. Revenue guidance of $40 million also fell short of expectations for almost $48 million. Aerohive shares dropped 18.29 percent to $4.60 in the after-hours trading session.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.